CLINICAL_TRIALS
trial_result
· 2014-05-20
Clinical Trial Update: Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia [Phase 4]
Summary
This clinical trial update reports a completed Phase 4 study of rituximab plus chemotherapy for CD20-positive adult acute lymphoblastic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ruijin Hospital | Conditions: Acute Lymphoblastic Leukemia | Phase 4 | Status: COMPLETED